Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 2 |
2005 | 1 |
2006 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
J Am Coll Cardiol. 2004 Sep 15;44(6):1194-9. doi: 10.1016/j.jacc.2004.06.049.
J Am Coll Cardiol. 2004.
PMID: 15364319
Free article.
Clinical Trial.
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
Exaire JE, Butman SM, Ebrahimi R, Kleiman NS, Harrington RA, Schweiger MJ, Bittl JA, Wolski K, Topol EJ, Lincoff AM; REPLACE-2 Investigators.
Exaire JE, et al.
Am Heart J. 2006 Jul;152(1):157-63. doi: 10.1016/j.ahj.2005.09.004.
Am Heart J. 2006.
PMID: 16824849
Item in Clipboard
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ; REPLACE-2 Investigators.
Lincoff AM, et al.
JAMA. 2003 Feb 19;289(7):853-63. doi: 10.1001/jama.289.7.853.
JAMA. 2003.
PMID: 12588269
Clinical Trial.
Item in Clipboard
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy).
Blankenship JC, Haldis T, Feit F, Hu T, Kleiman NS, Topol EJ, Lincoff AM; REPLACE-2 Investigators.
Blankenship JC, et al.
Am J Cardiol. 2006 Jun 1;97(11):1591-6. doi: 10.1016/j.amjcard.2005.12.050. Epub 2006 Apr 7.
Am J Cardiol. 2006.
PMID: 16728220
Clinical Trial.
Item in Clipboard
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ; REPLACE-2 Investigators.
Lincoff AM, et al.
JAMA. 2004 Aug 11;292(6):696-703. doi: 10.1001/jama.292.6.696.
JAMA. 2004.
PMID: 15304466
Clinical Trial.
Item in Clipboard
Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).
Chew DP, Lincoff AM, Gurm H, Wolski K, Cohen DJ, Henry T, Feit F, Topol EJ; REPLACE-2 Investigators.
Chew DP, et al.
Am J Cardiol. 2005 Mar 1;95(5):581-5. doi: 10.1016/j.amjcard.2004.11.003.
Am J Cardiol. 2005.
PMID: 15721095
Clinical Trial.
Item in Clipboard
Cite
Cite